On the 4th of September, in the prestigious magazine PloS One, Tiago Fleming Outeiro, head of the Unit of Cell and Molecular Neurosciences at the Institute of Molecular Medicine (IMM) published, along with researchers from the USA, a study that shows new clues about the action of dopamine, a central nervous system stimulant, on Parkinson’s disease. The study was carried out at Harvard Medical School (USA) and at the IMM, and had the collaboration of Portuguese, American and German researchers. Parkinson’s disease is characterised by the degeneration and death of neurons in a region of the brain, the substancia nigra. […]